Qualcomm will pay Huawei for patents. That has never happened before

Huawei said on Monday it has agreed a multi-year, broad patent licence with Qualcomm — a cross-licence spanning each company's portfolio in 5G, computing, artificial intelligence and networking, together with Qualcomm's purchase of certain Huawei US patents in compute, AI and networking. The announcement came out of Shenzhen before the US open. Qualcomm traded up about 3% in the pre-market.

The headline detail is the direction of the money. Huawei first paid to license Qualcomm's patents in 2001, and for most of the two decades since, the flow ran one way. Nikkei Asia reported that this cross-licence, if approved, makes Qualcomm the net payer to Huawei for the first time. Huawei described it as its first patent licensing deal with Qualcomm covering 5G technologies.

What the agreement actually covers

Three components, as described by the companies:

• Cross-licences to both patent portfolios across 5G, compute, AI and networking.
• Qualcomm's purchase of certain Huawei US patents in compute, AI, networking and other technologies.
• A commitment framed around fair, reasonable and non-discriminatory (FRAND) licensing principles.

John Han, executive vice president and general manager of Qualcomm Technology Licensing, said the agreement "reaffirms industry recognition of Qualcomm's 5G technology leadership and the success of Qualcomm's 5G SEP licensing program," and that it "likewise reflects Qualcomm's recognition of Huawei's continued innovation and intellectual property in 5G and other technology fields." Huawei said the deal demonstrates the value of its own innovations while recognising Qualcomm's foundational contributions to modern communications.

Why a licensing deal is a business story, not a legal footnote

Qualcomm's licensing arm is one of the most profitable franchises in semiconductors: it collects royalties on handsets built with standard-essential patents the company owns, whether or not Qualcomm supplies the chip. Anything that changes the terms of that business — a new payer, a new payee, a new cross-licence with a major holder of 5G patents — changes the arithmetic of the segment.

Huawei, barred from much of the US market for its own products, has spent years converting its research spending into a licensing business instead. Its deal with HP announced in August and now this Qualcomm agreement are the clearest evidence of that pivot. A patent portfolio is one of the few assets export controls do not switch off.

The regulatory question

Neither company has closed anything yet. Both said the transaction completes after the necessary regulatory approvals, and the US patent purchase in particular invites review: a US company acquiring patents from a Chinese company that sits on American restricted-entity lists is not a routine filing. Nikkei reported the arrangement will trigger a US regulatory review.

That is the gap between announcement and effect. The strategic logic — two of the largest holders of wireless standard-essential patents agreeing terms instead of litigating them — is clear today. The cash flows are not, because the companies have not disclosed the economics and the agreement has not cleared.

The context around it

The deal lands in a week when the single-stock news has rotated away from AI capex. Schneider Electric agreed on Monday to buy PTC for $22.6 billion in cash at a 42.3% premium, and the Philadelphia Semiconductor Index rose 2.4% on Friday with Nvidia touching an intraday record. Chip-sector sentiment has been strong; what is new here is a transaction built on intellectual property rather than on wafers, racks or data-centre capacity.

For Qualcomm, the question analysts will ask on the next earnings call is simple and not yet answerable: what does being a net payer cost, and what does the cross-licence remove in the way of future litigation risk? Until the companies disclose terms, anyone putting a number on that is guessing.